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Objective: Despite a growing body of Magnetic Resonance Imaging (MRI) literature in osteoarthritis (OA),
there is little uniformity in its diagnostic application. We envisage in the ﬁrst instance the deﬁnition
requiring further validation and testing in the research setting before considering implementation/
feasibility testing in the clinical setting. The objective of our research was to develop an MRI deﬁnition of
structural OA.
Methods: We undertook a multistage process consisting of a number of different steps. The intent was to
develop testable deﬁnitions of OA (knee, hip and/or hand) on MRI. This was an evidence driven approach
with results of a systematic review provided to the group prior to a Delphi exercise. Each participant of
the steering group was allowed to submit independently up to ﬁve propositions related to key aspects in
MRI diagnosis of knee OA. The steering group then participated in a Delphi exercise to reach consensus
on which propositions we would recommend for a deﬁnition of structural OA on MRI. For each round of
voting, 60% votes led to include and 20% votes led to exclude a proposition. After developing the
proposition one of the deﬁnitions developed was tested for its validity against radiographic OA in an
extant database.
Results: For the systematic review we identiﬁed 25 studies which met all of our inclusion criteria and
contained relevant diagnostic measure and performance data. At the completion of the Delphi voting
exercise 11 propositions were accepted for deﬁnition of structural OA on MRI. We assessed the diagnostic
performance of the tibiofemoral MRI deﬁnition against a radiographic reference standard. The diagnostic
performance for individual features was: osteophyte C statistic¼ 0.61, for cartilage loss C statistic¼ 0.73,
for bone marrow lesions C statistic¼ 0.72 and for meniscus tear in any region C statistic¼ 0.78. The
overall composite model for these four features was a C statistic¼ 0.59. We detected good speciﬁcity (1)
but less optimal sensitivity (0.46) likely due to detection of disease earlier on MRI..J. Hunter, Rheumatology Department, Royal North Shore Hospital and Northern Clinical School, University of Sydney,
ax: 61-2-9906-1859.
Hunter).
s Research Society International. Published by Elsevier Ltd. All rights reserved.
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 963e969964Conclusion: We have developed MRI deﬁnition of knee OA that requires further formal testing with
regards their diagnostic performance (especially in datasets of persons with early disease), before they
are more widely used. Our current analysis suggests that further testing should focus on comparisons
other than the radiograph, that may capture later stage disease and thus nullify the potential for
detecting early disease that MRI may afford. The propositions are not to detract from, nor to discourage
the use of traditional means of diagnosing OA.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The American College of Rheumatology (ACR) classiﬁcation
criteria have been the mainstay for diagnosing osteoarthritis (OA)
both in the clinic and in research settings1. The clinical criteria
include a combination of the patient’s age, signs and symptoms on
physical exam, and further criteria also include the addition of
radiographic and/or laboratory evidence. When the radiograph is
used along with a physical exam, the sensitivity and speciﬁcity of
this combined method for OA diagnosis are 91% and 86%, respec-
tively. The standard against which the classiﬁcation criteria were
judged was the clinical diagnosis of OA. This radiograph based
diagnostic method is cheap and readily available. Although the ACR
combined clinical and radiographic criteria remains the standard
for diagnosis both in the clinic and in research, it relies upon
conventional radiographs which means they may be less sensitive
to detecting early structural changes of OA.
In a more recent effort to deﬁne OA, the European League
Against Rheumatism (EULAR) OA Task Force suggested that
a conﬁdent clinical diagnosis of knee OA may be made according to
three symptoms (persistent knee pain, morning stiffness and
reduced function) and three signs (crepitus, restricted movement
and bony enlargement)2. Part of the research agenda posed by this
group was to examine the diagnostic relevance of MRI for OA.
MRI potentially affords inherent advantages for a structural
diagnosis of OA of whole organ assessment with multiplanar
acquisitions. The potential for MRI to be more sensitive to earlier
disease, detecting change, and the capacity of this technology to
visualize joint structural changes beyond gross changes in bone and
in the joint space, has resulted in great interest in the use of MRI for
assessing diagnostic status, disease severity and monitoring
progression3,4. Increasingly, MRI is being used in clinical practice to
facilitate diagnostic decisions. Because of cost concerns, as well as
lack of clarity about diagnostic performance and little standardi-
zation regardingMRI interpretation, it is unclear, however, whether
this increased use of MRI in clinical practice is rational. In the
research setting, some have proposed recruiting persons with early
disease as deﬁned on MRI into Disease Modifying Osteoarthritis
Drug (DMOAD) trials where currently no existing deﬁnition exists.
Due to these inherent concerns about the application of MRI to
facilitate OA diagnosis it is important that this be more rigorously
tested. Despite a growing body of MRI literature in OA, there is little
uniformity in its diagnostic application. This lack of uniformity may
stem from the absence of criteria for an MRI OA structural diag-
nosis. We would envisage in the ﬁrst instance the development of
an MRI deﬁnition would require further validation and testing in
the research setting before considering implementation/feasibility
testing in the clinical setting.
In the absence of MRI criteria for OA diagnosis there are
a number of different methods that could be used to reach
consensus. One of the methods used more commonly in the
medical literature is the Delphi process5,6. With this background,
the objective of our research was to develop an MRI deﬁnition of
structural OA. More speciﬁcally, the intent was to ﬁnd what
structural changes on MRI would constitute a structural diagnosisof OA and develop testable deﬁnitions of OA (knee, hip and/or
hand) on MRI. In addition, we began the formal assessment of the
diagnostic performance of the proposed deﬁnition although this
will require much further testing.
Materials and methods
The MRI-based deﬁnition of structural OA was developed using
an evidence driven approach with results of a systematic review
provided to an expert group prior to a Delphi exercise. We
undertook a multistage process consisting of a number of steps.
1. Systematic Review. As part of a larger Osteoarthritis Research
Society International (OARSI) Food and Drug Administration
(FDA) OA initiative we undertook a systematic review of the OA
MRI literature for the purpose of assessing the clinometric
properties of MRI measurements in knee OA. An online litera-
ture search was conducted of the OVID MEDLINE (1945-),
EMBASE (1980-) and Cochrane databases (1998-) of articles
published up to the time of the search, April 2009, with the
search entries “MRI”, and “osteoarthritis”. All articles which
used MRI, in some form, on patients with osteoarthritis of the
knee, hip, or hand were included. Only studies published in
English were included. Studies presenting non-original data
were excluded, such as reviews, editorials, opinion papers, or
letters to the editor. In addition to the clinometric properties
(reliability, responsiveness and validity are the focus of sepa-
rate ongoing analyses) of MRI in OA, details on rigor of study
design to construct the Downs methodological quality score7,
we also extracted data pertaining to the diagnostic perfor-
mance of MRI. Data was extracted on the diagnostic perfor-
mance of MRI or material pertaining to deﬁning OA on MRI
which is the focus of this manuscript. The ability of MRI to
discriminate between patients with and without knee OA
(diagnosed using different reference standards including radi-
ography and arthroscopy) was summarized by sensitivity,
speciﬁcity, positive and negative predictive values (PPV, NPV).
The pooled data from the literature search were shared with
the OA Imaging Working Group via an interactive website and
other interestedmembers of the OA community during a public
meeting.
2. Steering group. A multidisciplinary, geographically diverse
steering group was selected on the basis of content and/or
methods expertise and was invited to participate in the OAMRI
deﬁnition development project by OARSI. The steering group
(the listed co-authors) met by teleconference and were invited
to propose MRI deﬁnitions of OA. Each participant was allowed
to submit independently up to ﬁve propositions related to key
aspects in MRI diagnosis of knee OA.
3. Delphi exercise. The steering group then participated in a Delphi
exercise to reach consensus on which propositions we would
recommend for a deﬁnition of structural OA on MRI5. For each
round of voting, 60% votes led to include and 20% votes led
to exclude a proposition. Propositions receiving 20e60% votes
were discussed and another round of voting was taken. The
Table I
Diagnostic performance of all MRI techniques measured against gold standards,
separated by gold standard used
Gold standard used Mean Median Min Max No. of
entries
Arthroscopy
(23 studies)
Sensitivity 68.7% 72% 17% 100% 66
Speciﬁcity 88% 93.9% 58% 99.96% 44
PPV 75% 84.7% 48% 92.2% 7
NPV 92.2% 94% 78% 100% 7
X-ray (20 studies) Sensitivity 56.4% 60% 18% 90% 11
Speciﬁcity 85.2% 85% 67% 96% 11
PPV 49% 49% 48% 50% 2
NPV 87% 87% 86% 88% 2
Histology (17 studies) Sensitivity 68.4% 69% 36% 93% 17
Speciﬁcity 75.5% 72.4% 62% 100% 5
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included or excluded.
4. Scientiﬁc Community Feedback. The systematic review data on
the diagnostic performance of MRI in OA and the MRI OA
deﬁnition propositions after initial rounds of the Delphi exer-
cise were presented at a public meeting in Montreal
(September 2009) during the OARSI annual scientiﬁc meeting
to gain feedback on the initiative. The scientiﬁc community
feedback occurred between rounds 2 and 3 of the Delphi
exercise and was used to inform wording for the Delphi
propositions for the third round.
5. Diagnostic performance in Osteoarthritis Initiative (OAI). To move
beyond consensus and to test the validity or otherwise of the
deﬁnition requires assessing the diagnostic performance of the
newdeﬁnition against the current reference standard. There are
a number ofmeans of deﬁning OA but themost commonly used
means in current research studies is the use of the Kellgren and
Lawrence (KL) grade, with those having OA deﬁned as 2. To
this endwe have assessed theMRI deﬁnition of tibiofemoral OA
(deﬁnition 10) as proposed in this manuscript against this
reference standard. We also acknowledge that other constructs
could be used for comparison and that further assessing the
validity of the proposed deﬁnitions is required. This analysis
was conducted in an existing dataset that we have previously
published8. These are 160 participants from the progression
sub-cohort of the OAI Study, an ongoing multi-center study,
focusing on knee OA. Sixteen percent of the study sample did
not have radiographic OA using the commonly accepted criteria
of KL grade 2. For this analysis we have included osteophyte,
cartilage loss, bone marrow lesion, and meniscus. Statistical
analyses were performed using SAS software, (SAS Institute Inc,
Cary, North Carolina, release 8.2). This analysis was conducted
after development of the deﬁnition. Further given the timing of
conducting these analyses, after the Delphi was complete, they
did not inform that process.
Results
Systematic literature review
Weidentiﬁed25studieswhichmet all of our inclusion criteria and
contained relevant diagnostic measure and performance data. The
studies included a total of 2704 participants, 1733 with OA and 971
without OA. Three of the studies focused on the hip, one on the hand
and the remainder focused upon the knee. A large majority of the
studies used semi-quantitative MRI measurement techniques for
measuring OA. The only other measurement technique appearing
more than once was quantitative measurement of cartilage
morphology (thickness, volume). Various tissues were imaged in the
different studies. In themajorityof studies cartilagewasexamined (19
studies). The two other commonly viewed tissue types were
meniscus (eight studies) and synovium (three studies). As the gold
standardmeasure againstwhich theMRI diagnostic techniqueswere
compared, arthroscopy was used most frequently, followed by
radiographs, and histological section. Table I reﬂects the diagnostic
performanceof allMRI techniques against thevariousgold standards.
The diagnostic performance of MRI varied markedly depending on
which reference standard it was compared to. In general the MRI
performance was better when it was compared to the tissue of
interest directly (e.g., arthroscopy, histology) as distinct from X-ray.
Delphi results
The steering groupmembers provided a total of 53 propositions.
Prior to the ﬁrst round of voting, any redundant (overlapping)propositions were amalgamated. During the ﬁrst round of voting,
ﬁve propositions were rejected and one was accepted.
The second round commenced with 19 propositions for voting.
During the second round a further two propositions were rejected
and a further seven were accepted and one redundant proposition
was combined.
The third round commenced with nine propositions requiring
further voting. After completion of the third round, three of these
were accepted and a further six were rejected. Thus at the
completion of the Delphi voting exercise 11 propositions were
accepted for deﬁnition of structural OA on MRI (Table II).
The ﬁrst nine of the propositions listed in the table provide an
important conceptual framework or “preamble” for the MRI deﬁ-
nition of structural OA. Propositions 10 and 11 are testable deﬁni-
tions in other datasets.Assessing diagnostic performance of proposed deﬁnition
Thediagnostic performance of theproposeddeﬁnitionwas tested
in 160 participants from the progression sub-cohort of the OAI
Study8. Sixteen percent of the study sample did not have radio-
graphic OA using the commonly accepted criteria of KL grade 2.
Osteophyte
The analysis of the osteophyte volume using the Dual Echo
Steady State (DESS) sequences was done within the segmentation
process from a former study8, investigating cartilage morphometry
changes in participants out of the OAI database. For this analysis
osteophyte volume in the tibiofemoral joint was assessed as the
sum of osteophyte volume at the medial and lateral tibia as well as
medial and lateral femur. The reference standard for comparison of
diagnostic performance was radiographic OA; deﬁned as KL
grade 29 in the same knee.
For osteophyte volume:
(a) cutpoint¼ 50 mm3, c¼ 0.53
(b) cutpoint¼ 100 mm3, c¼ 0.52
(c) cutpoint¼ 200 mm3, c¼ 0.61 [see Fig. 1(a)].Full thickness cartilage loss
The cartilage segmentation was done using DESS MRI sagittal
sequences acquired by the OAI. The DESS sequence provides
a complete high-resolution view of the knee cartilage tissue with
good contrast and separation between ﬂuid, cartilage, meniscus
and bony tissue. The segmentation, analysis methods and propri-
etary software have been previously described8,10,11. After image
segmentation, the following measures were analyzed:
Table II
Accepted propositions for deﬁnition of OA on MRI after Delphi voting completion
Preamble
1 MRI changes of OA may occur in the absence of radiographic ﬁndings
of OA.
2 MRI may add to the diagnosis of OA and should be incorporated into the
ACR diagnostic criteria including X-ray, clinical and laboratory parameters.
3 MRI may be used for inclusion in clinical studies according to criteria
deﬁned above but should not be a primary diagnostic tool in a
clinical setting.
4 Certain MRI changes in isolation including cartilage loss, cartilage
compositional change, cystic change and bone marrow lesions, ligamentous
and tendinous damage, meniscal damage, and effusion and synovitis are
not diagnostic of osteoarthritis.
5 No single MR ﬁnding is diagnostic of knee OA.
6 MRI ﬁndings indicative of knee OA may include abnormalities in all
tissues of the joint: bone, cartilage meniscus, synovium, ligament
and capsule.
7 Given the multiple tissue abnormalities detected by MRI in OA, diagnostic
criteria are likely to involve several possible combinations of features.
8 Deﬁnite osteophyte formation is indicative of osteoarthritis.*
9 Joint space narrowing assessed by (non-weight bearing) MRI cannot be
used as a diagnostic criterion.
Deﬁnitions
10 A deﬁnition of tibiofemoral osteoarthritis on MRI would be:
The presence of both group [A] features or one group [A] feature and two
or more group [B] features
Group [A] after exclusion of joint trauma within the last 6 months
(by history) and exclusion of inﬂammatory arthritis (by radiographs,
history and laboratory parameters):
i) Deﬁnite osteophyte formation*
ii) Full thickness cartilage loss
Group [B]:
i) Subchondral bone marrow lesion or cyst not associated with meniscal or
ligamentous attachments
ii) Meniscal subluxation, maceration or degenerative (horizontal) tear
iii) Partial thickness cartilage loss (where full thickness loss is not present)
iv) Bone attrition
11 Deﬁnition of PF OA requires all of the following involving the patella and/or
anterior femur:
i) A deﬁnite osteophyte
ii) Partial or full thickness cartilage loss
* The deﬁnition of a ‘deﬁnite osteophyte’was not delineated in the Delphi process
and requires further validation.
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2. Normalized Cartilage volume (Volume normalized to bone
surface interface area).
3. Denuded area (Total Cartilage Bone Interface area denuded of
cartilage). The denuded area is the area of bone where a full
thickness cartilage defect is present.
For cartilage loss we used the denuded area and depicted this at
two different cutpoints based upon prior data12:
(a) cutpoint¼ 0 mm2, c¼ 0.65
(b) cutpoint¼ 10 mm2, c¼ 0.73 [see Fig. 1(b)].Bone marrow lesion
On the sagittal intermediate-weighted (IW) Turbo Spin Echo
(TSE) fat-suppressed images (FS) a Bone Marrow Lesion (BML) was
described when seeing an irregular hyperintense signal in the
subchondral bone, proximal to the epiphyseal line. The size of the
BMLs was evaluated for size from 0 to 3 at each of the following
locations using Boston–Leeds Osteoarthritis Knee Score (BLOKS)13:
medial and lateral weight-bearing femur, and medial and lateral
tibia. We classiﬁed BMLs as present in any region (>0) and also
those with BLOKS score> 1 in any region.For BML:
(a) cutpoint¼ 0, c¼ 0.54
(b) cutpoint¼ 1, c¼ 0.72 [see Fig. 1(c)].Degenerative meniscal tear
The sagittal IW TSE FS sequences, were used to score the
meniscal integrity using the Whole-Organ Magnetic Resonance
Imaging Score (WORMS) grading system14. The anterior horn, body
segment and posterior horn of each of the medial and lateral
menisci were graded from 0 to 4 based on both the sagittal and
coronal images: 0¼ intact; 1¼minor radial tear or parrot-beak
tear; 2¼ nondisplaced tear; 3¼ displaced tear or partial resec-
tion; 4¼ complete maceration/destruction or complete resection.
For meniscal abnormality we scored this as present in any
region (>0) and also those with score 2.
For meniscus:
(a) cutpoint¼ 0, c¼ 0.5
(b) cutpoint¼ 2, c¼ 0.78 [see Fig. 1(d)].Composite
We also assessed the formation of a composite model including
all of these features. For the composite model we used the most
discriminatory cutpoints from the above features. Thus for osteo-
phyte we used a threshold of 200 mm3 (C statistic for individual
model¼ 0.61), for cartilage loss we used a cutpoint of 10 mm2
(C statistic for individual model¼ 0.73), for BML> 1 (C statistic for
individual model¼ 0.72) and for meniscus 2 in any region
(C statistic for individual model¼ 0.78). Overall composite model
C statistic¼ 0.59 [see Fig. 1(e)].
Discussion
OA is a complexdisease characterizedby involvementofmultiple
tissues in the synovial joint15. The results of the Delphi process
present a number of propositions that are statements of preamble
and context setting (propositions one to nine). By their nature the
preamble statementswill be difﬁcult to formally test and assist here
in providing context for the two deﬁnitions proposed.
For clariﬁcation the statement in proposition eight may appear
to contradict that in proposition ﬁve however the use of the word
“indicative”which ultimatelymeans suggestive,means that it is not
incontrovertible proof of OA.
The impetus behind imaging developments in OA is primarily to
facilitate therapeutic development of interventions that modify
joint structure. A number of concerns have been raised about the
feasibility of disease modifying approaches using current plain
radiographic technologies, as this captures persons with late stage
disease that may not be amenable to such interventions16. The
motivation to includeMRI as ameans of deﬁning disease is with the
intent that one may be able to identify early, pre-radiographic
disease, thus enabling recruitment of study populations where
structure modiﬁcation (or structure maintenance) may be realistic
in a more preventative manner. Prior to using the deﬁnitions that
have been developed, it is important that they be adequately tested.
We have begun this process but it requires much more assess-
ment particularly focusing on cohorts with early, pre-radiographic
disease. The overall composite model C statistic was a disap-
pointing 0.59. It is important to indicate that there was a small
number of persons without radiographic OA in this dataset and the
speciﬁcity for this diagnosis was ¼1. Not surprisingly given the
potential for MRI to detect earlier disease the sensitivity was 0.46.
Fig. 1. (a) Osteophyte volume e the Receiver Operating Characteristic (ROC) curve for the cutpoint of 200 mm3. (b) Cartilage loss e the ROC curve for the cutpoint of 10 mm2.
(c) BML e the ROC curve for the cutpoint of BML> 1 in any region. (d) Meniscus e the ROC curve for the cutpoint of meniscal score 2 in any region. (e) Composite ROC curve.
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sets both using the construct of radiographic OA as well as other
endpoints including the presence of symptoms.
The next step in testing the validity of the deﬁnitions developed
would be to formally test their diagnostic performance against other
current diagnostic standards, ideally in at least two independent
datasets. Many of the propositions do not lend themselves to formal
validity testing, being statements to create context or to set limita-
tions of MRI in this arena. Propositions 10 and 11 do, however, offer
an opportunity for formal testing against other diagnostic
constructs, such as plain radiography or clinical diagnosis.The lack of a universally agreed reference standard does, however,
create a challengewith regardsperforming suchanalyses.MRIhas the
potential todiagnoseOAearlier than thecurrent reference standardof
radiographyand there is little consensus onwhat representsOAusing
other potential reference standards such as arthroscopy. The lack of
a recognized gold standard and the variety of gold standards used in
the systematic review prior to the Delphi exercise may have intro-
duced complexity that could have adversely inﬂuenced decision
making in the Delphi voting. Novel methods may assist here in the
absence of a perfect gold standard that make estimates of the true
prevalence based on the outcome of different tests17,18.
D.J. Hunter et al. / Osteoarthritis and Cartilage 19 (2011) 963e969968The goal of this exercise was to bring leading experts in OAwith
some expertise in MRI together to agree as much as possible on
deﬁnitions that could be published and suggested for free use in
future studies. Ultimately, however, the exercise was primarily
dependent upon an expert consensus based approach19. This has
limitations that need to be acknowledged including that it is based
on the subjective opinion of the participants, and the questionable
premise that ‘pooled intelligence’ enhances individual judgement
and captures the collective opinion of experts6.
It is important to recognize that the propositions have been
developed for structural OA, not for a clinical diagnosis, not for early
OA, andnot to facilitate stagingof thedisease. Someof theelementsof
different propositions have questionable clinical relevance including
theosteophyte thatmay simply be an adaptive/reparative response to
altered alignment20. These further steps in developing the utility of
MRI in the setting of OAwill naturally follow from this work.
In addition to this work, the OARSI OA ImagingWorking group is
intending to develop a core set of sequences that can facilitate
application of MRI in OA for diagnosis, staging and assessing
progression. Some modiﬁcation of existing scoring techniques may
be required to facilitate these goals14,15.
Using a modiﬁed Delphi approach we have developed 11
propositions for deﬁnition of OA on MRI. The aim for their devel-
opment is that they be formally tested regarding their diagnostic
performance, before they are more widely used. The propositions
are not to detract from, nor to discourage the use of traditional
means of diagnosing OA.
In our preliminary analysis of the diagnostic performance of the
tibiofemoral deﬁnition we detected good speciﬁcity but less
optimal sensitivity that is likely due to detection of disease earlier
on MRI. Our current analysis suggests that further testing should
focus on comparisons other than the radiograph, that may capture
later stage disease and thus nullify the potential for detecting early
disease that MRI may afford.
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